130 related articles for article (PubMed ID: 9101188)
1. Pharmacokinetic investigation of fusidic acid 1% viscous eye drops in healthy volunteers.
Thorn P; Johansen S
Eur J Ophthalmol; 1997; 7(1):9-12. PubMed ID: 9101188
[TBL] [Abstract][Full Text] [Related]
2. Fusidic acid in tear fluid: pharmacokinetic study with fusidic acid viscous eye drops.
van Bijsterveld OP; Andriesse H; Nielsen BH
Eur J Drug Metab Pharmacokinet; 1987; 12(3):215-8. PubMed ID: 3436345
[TBL] [Abstract][Full Text] [Related]
3. Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops.
Jackson WB; Low DE; Dattani D; Whitsitt PF; Leeder RG; MacDougall R
Can J Ophthalmol; 2002 Jun; 37(4):228-37; discussion 237. PubMed ID: 12095096
[TBL] [Abstract][Full Text] [Related]
4. Fusidic acid viscous eyedrops--an evaluation of pharmacodynamics, pharmacokinetics and clinical use for UK optometrists.
Doughty MJ; Dutton GN
Ophthalmic Physiol Opt; 2006 Jul; 26(4):343-61. PubMed ID: 16792734
[TBL] [Abstract][Full Text] [Related]
5. Tear concentration and safety of levofloxacin ophthalmic solution 1.5% compared with ofloxacin ophthalmic solution 0.3% after topical administration in healthy adult volunteers.
Walters T; Rinehart M; Krebs W; Holdbrook M
Cornea; 2010 Mar; 29(3):263-8. PubMed ID: 20098307
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of fusidic acid: rationale for front-loaded dosing regimens due to autoinhibition of clearance.
Bulitta JB; Okusanya OO; Forrest A; Bhavnani SM; Clark K; Still JG; Fernandes P; Ambrose PG
Antimicrob Agents Chemother; 2013 Jan; 57(1):498-507. PubMed ID: 23147726
[TBL] [Abstract][Full Text] [Related]
7. Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics.
Turnidge J
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S23-34. PubMed ID: 10528784
[TBL] [Abstract][Full Text] [Related]
8. [Comparative diffusion of fusidic acid, oxacillin, and pristinamycin in dermal interstitial fluid after repeated oral administration].
Vaillant L; Le Guellec C; Jehl F; Barruet R; Sorensen H; Roiron R; Autret-Leca E; Lorette G
Ann Dermatol Venereol; 2000 Jan; 127(1):33-9. PubMed ID: 10717560
[TBL] [Abstract][Full Text] [Related]
9. Ocular availability of gentamicin in small animals after topical administration of a conventional eye drop solution and a novel long acting bioadhesive ophthalmic drug insert.
Gurtler F; Kaltsatos V; Boisramé B; Deleforge J; Gex-Fabry M; Balant LP; Gurny R
Pharm Res; 1995 Nov; 12(11):1791-5. PubMed ID: 8592688
[TBL] [Abstract][Full Text] [Related]
10. The clinical efficacy of topical and systemic therapy for the treatment of feline ocular chlamydiosis.
Sparkes AH; Caney SM; Sturgess CP; Gruffydd-Jones TJ
J Feline Med Surg; 1999 Mar; 1(1):31-5. PubMed ID: 11919013
[TBL] [Abstract][Full Text] [Related]
11. Acute conjunctivitis. A comparison of fusidic acid viscous eye drops and chloramphenicol.
Hørven I
Acta Ophthalmol (Copenh); 1993 Apr; 71(2):165-8. PubMed ID: 8333258
[TBL] [Abstract][Full Text] [Related]
12. Tear concentrations of levofloxacin following topical administration of a single dose of 0.5% levofloxacin ophthalmic solution in healthy volunteers.
Raizman MB; Rubin JM; Graves AL; Rinehart M
Clin Ther; 2002 Sep; 24(9):1439-50. PubMed ID: 12380635
[TBL] [Abstract][Full Text] [Related]
13. Fusidic acid prophylaxis before cataract surgery: patient self-administration.
Gray TB; Keenan JI; Clemett RS; Allardyce RA
Aust N Z J Ophthalmol; 1993 May; 21(2):99-103. PubMed ID: 8333941
[TBL] [Abstract][Full Text] [Related]
14. Ciprofloxacin ophthalmic solution in the treatment of conjunctivitis and blepharitis: a comparison with fusidic acid.
Adenis JP; Colin J; Verin P; Riss I; Saint-Blancat P
Eur J Ophthalmol; 1996; 6(4):368-74. PubMed ID: 8997576
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and safety of single, multiple, and loading doses of fusidic acid in healthy subjects.
Still JG; Clark K; Degenhardt TP; Scott D; Fernandes P; Gutierrez MJ
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S504-12. PubMed ID: 21546627
[TBL] [Abstract][Full Text] [Related]
16. Fusidic acid in acute conjunctivitis. Single-blind, randomized comparison of fusidic acid and chloramphenicol viscous eye drops.
Hvidberg J
Acta Ophthalmol (Copenh); 1987 Feb; 65(1):43-7. PubMed ID: 3554881
[TBL] [Abstract][Full Text] [Related]
17. Tear concentrations of azithromycin following topical administration of a single dose of azithromycin 0.5%, 1.0%, and 1.5% eyedrops (T1225) in healthy volunteers.
Chiambaretta F; Garraffo R; Elena PP; Pouliquen P; Delval L; Rigal D; Dubray C; Goldschmidt P; Tabbara K; Cochereau I
Eur J Ophthalmol; 2008; 18(1):13-20. PubMed ID: 18203079
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and tolerance of a new film-coated tablet of sodium fusidate administered as a single oral dose to healthy volunteers.
Macgowan AP; Greig MA; Andrews JM; Reeves DS; Wise R
J Chemother; 1989 Jul; 1(4 Suppl):593-6. PubMed ID: 16312548
[No Abstract] [Full Text] [Related]
19. [Hydrogel, a new galenic form in ophthalmology].
Kaiser RR; Rückert PR
Klin Monbl Augenheilkd; 1990 May; 196(5):405-6. PubMed ID: 2366486
[TBL] [Abstract][Full Text] [Related]
20. Determination of ofloxacin in tear by HPLC-ESI-MS/MS method: comparison of ophthalmic drug release between a new mucoadhesive chitosan films and a conventional eye drop formulation in rabbit model.
Byrro RM; de Oliveira Fulgêncio G; da Silva Cunha A; César IC; Chellini PR; Pianetti GA
J Pharm Biomed Anal; 2012 Nov; 70():544-8. PubMed ID: 22673938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
